Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic evaluation of deimplementation interventions: a systematic review.

BMJ quality & safety·2026
Same author

Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.

Palliative medicine·2026
Same author

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project.

Cancers·2026
Same author

Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic review.

Psychological medicine·2026
Same author

Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study.

Lancet (London, England)·2026
Same author

Understanding the Factors Explaining the Growing Use of Medical Assistance in Dying in Québec: Protocol for an Interdisciplinary Mixed Methods and Multimethods Study.

JMIR research protocols·2026

Related Experiment Video

Updated: Jun 13, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation.

Michel Dorval1,2,3,4, Virginie Audet-Croteau2,3,4,5, Sue-Ling Chang2,3,4

  • 1Faculty of Pharmacy, Université Laval, Quebec, QC G1V 0A6, Canada.

Healthcare (Basel, Switzerland)
|June 12, 2026
PubMed
Summary

Psilocybin-assisted therapy (PAT) shows promise for cancer patients, but implementation in palliative care faces significant barriers. After one year, no patients received PAT due to regulatory and logistical challenges, despite perceived clinical value.

Keywords:
cost analysisexistential distressimplementationpalliative carepsilocybin-assisted therapyqualitative analysis

Related Experiment Videos

Last Updated: Jun 13, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Area of Science:

  • Oncology
  • Palliative Care
  • Psychedelic Research

Background:

  • Psilocybin-assisted therapy (PAT) offers potential for managing existential distress in advanced cancer patients.
  • Integration of PAT into routine oncology and palliative care is not well-established.

Purpose of the Study:

  • To examine real-world PAT implementation in a Canadian tertiary care center.
  • Identify factors influencing PAT adoption and estimate integration costs.

Main Methods:

  • A single-case implementation study design was used.
  • Semi-structured interviews with 10 clinicians and managers explored barriers and facilitators.
  • A budget impact analysis estimated incremental costs.

Main Results:

  • No patients received PAT within the first year of introduction.
  • Key barriers included administrative, regulatory, and logistical issues.
  • Perceived clinical relevance and institutional leadership were facilitators.
  • Estimated PAT delivery costs ranged from 2648 to 5827 CAD per patient.

Conclusions:

  • A significant gap exists between regulatory approval and actual service uptake for PAT.
  • Structured implementation strategies and alignment of regulatory frameworks with clinical workflows are crucial.
  • Sustained institutional support is necessary for successful PAT integration into palliative care.